Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Linking long-term dietary patterns with gut microbial enterotypes.

Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD.

Science. 2011 Oct 7;334(6052):105-8. doi: 10.1126/science.1208344. Epub 2011 Sep 1.

2.

The human gut virome: inter-individual variation and dynamic response to diet.

Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, Lewis JD, Bushman FD.

Genome Res. 2011 Oct;21(10):1616-25. doi: 10.1101/gr.122705.111. Epub 2011 Aug 31.

3.

High-fat diet determines the composition of the murine gut microbiome independently of obesity.

Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, Wu GD.

Gastroenterology. 2009 Nov;137(5):1716-24.e1-2. doi: 10.1053/j.gastro.2009.08.042. Epub 2009 Aug 23.

4.

Immune-mediated signaling in intestinal goblet cells via PI3-kinase- and AKT-dependent pathways.

Wang ML, Keilbaugh SA, Cash-Mason T, He XC, Li L, Wu GD.

Am J Physiol Gastrointest Liver Physiol. 2008 Nov;295(5):G1122-30. doi: 10.1152/ajpgi.90430.2008. Epub 2008 Oct 2.

5.

Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis.

McVay LD, Keilbaugh SA, Wong TM, Kierstein S, Shin ME, Lehrke M, Lefterova MI, Shifflett DE, Barnes SL, Cominelli F, Cohn SM, Hecht G, Lazar MA, Haczku A, Wu GD.

J Clin Invest. 2006 Nov;116(11):2914-23. Epub 2006 Oct 5.

6.
7.

RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract.

Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13596-600. Epub 2004 Aug 30.

8.

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD.

Am J Gastroenterol. 2001 Dec;96(12):3323-8.

PMID:
11774944
9.

High-level expression of I kappa B-beta in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role.

Wu GD, Huang N, Wen X, Keilbaugh SA, Yang H.

J Leukoc Biol. 1999 Dec;66(6):1049-56.

PMID:
10614789
10.

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD.

J Clin Invest. 1999 Aug;104(4):383-9.

11.

Association of GAP-43 with detergent-resistant membranes requires two palmitoylated cysteine residues.

Arni S, Keilbaugh SA, Ostermeyer AG, Brown DA.

J Biol Chem. 1998 Oct 23;273(43):28478-85.

12.

Evidence that the two C1q binding membrane proteins, gC1q-R and cC1q-R, associate to form a complex.

Ghebrehiwet B, Lu PD, Zhang W, Keilbaugh SA, Leigh LE, Eggleton P, Reid KB, Peerschke EI.

J Immunol. 1997 Aug 1;159(3):1429-36.

PMID:
9233640
13.

The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.

Peterson KL, Zhang W, Lu PD, Keilbaugh SA, Peerschke EI, Ghebrehiwet B.

Clin Immunol Immunopathol. 1997 Jul;84(1):17-26.

PMID:
9191880
14.

Effect of 2',3'-dideoxycytidine on oxidative phosphorylation in the PC12 cell, a neuronal model.

Keilbaugh SA, Hobbs GA, Simpson MV.

Biochem Pharmacol. 1997 May 15;53(10):1485-92.

PMID:
9260876
15.

Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation.

Hobbs GA, Keilbaugh SA, Rief PM, Simpson MV.

Biochem Pharmacol. 1995 Jul 31;50(3):381-90.

PMID:
7646539
16.

Association and colocalization of K+ channel alpha- and beta-subunit polypeptides in rat brain.

Rhodes KJ, Keilbaugh SA, Barrezueta NX, Lopez KL, Trimmer JS.

J Neurosci. 1995 Jul;15(7 Pt 2):5360-71.

17.

Mechanisms of toxicity of 3'-azido-3'-deoxythymidine. Its interaction with adenylate kinase.

Barile M, Valenti D, Hobbs GA, Abruzzese MF, Keilbaugh SA, Passarella S, Quagliariello E, Simpson MV.

Biochem Pharmacol. 1994 Oct 7;48(7):1405-12.

PMID:
7945440
20.

The PC12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs.

Keilbaugh SA, Prusoff WH, Simpson MV.

Biochem Pharmacol. 1991 Jun 21;42(1):R5-8. No abstract available.

PMID:
1648918
21.

Studies on the inhibition of mitochondrial DNA replication by 3'-azido-3'-deoxythymidine and other dideoxynucleoside analogs which inhibit HIV-1 replication.

Simpson MV, Chin CD, Keilbaugh SA, Lin TS, Prusoff WH.

Biochem Pharmacol. 1989 Apr 1;38(7):1033-6. No abstract available.

PMID:
2706007

Supplemental Content

Loading ...
Support Center